Aims. Loosening of components after
Aims.
Prophylactic antibiotics are important in reducing the risk of periprosthetic joint infection (PJI) following
Aims. Total hip arthroplasty (THA) and
Aims. The aim of this study was to compare a bicruciate-retaining (BCR)
Aims. Neither a surgeon’s intraoperative impression nor the parameters of computer navigation have been shown to be predictive of the outcomes following
Aims. This study aimed to evaluate if
Aims. The aim of this study was to compare any differences in the primary outcome (biphasic flexion knee moment during gait) of robotic arm-assisted bi-unicompartmental knee arthroplasty (bi-UKA) with conventional mechanically aligned
Aims. Inadvertent soft tissue damage caused by the oscillating saw during
Aims. Oxidised zirconium was introduced as a material for femoral components
in
Fixed flexion deformities are common in osteoarthritic
knees that are indicated for
The outcome of
We have previously reported the short-term radiological
results of a randomised controlled trial comparing kinematically
aligned
Tranexamic acid (TEA), an inhibitor of fibrinolysis,
reduces blood loss after routine
We report on the long-term results of 163 bicruciate-retaining
Hermes 2C
Patient-specific cutting guides (PSCGs) are designed
to improve the accuracy of alignment of
There has been a recent increase in interest
for non-cemented fixation in
In this study we present our experience with
four generations of uncemented total knee arthroplasty (TKA) from Smith
&
Nephew: Tricon M, Tricon LS, Tricon II and Profix, focusing
on the failure rates correlating with each design change. Beginning
in 1984, 380 Tricon M, 435 Tricon LS, 305 Tricon 2 and 588 Profix
were implanted by the senior author. The rate of revision for loosening
was 1.1% for the Tricon M, 1.1% for the Tricon LS, 0.5% for the
Tricon 2 with a HA coated tibial component, and 1.3% for the Profix
TKA. No loosening of the femoral component was seen with the Tricon
M, Tricon LS or Tricon 2, with no loosening seen of the tibial component
with the Profix
Aims. Conflicting clinical results are reported for the ATTUNE